Global Antimicrobial Susceptibility Test Market Research Report 2019

2 Global Antimicrobial Susceptibility Test Quarterly Market Size Analysis

• 2.1 Antimicrobial Susceptibility Test Business Impact Assessment - COVID-19
  • 2.1.1 Global Antimicrobial Susceptibility Test Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
• 2.2 Global Antimicrobial Susceptibility Test Quarterly Market Size 2020-2021
• 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
  • 2.3.1 Drivers
  • 2.3.2 Restraints
  • 2.3.3 Opportunities
  • 2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

• 3.1 By Players, Global Antimicrobial Susceptibility Test Quarterly Market Size, 2019 VS 2020
• 3.2 By Players, Antimicrobial Susceptibility Test Headquarters and Area Served
• 3.3 Date of Key Players Enter into Antimicrobial Susceptibility Test Market
• 3.4 Key Players Antimicrobial Susceptibility Test Product Offered
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Antimicrobial Susceptibility Test Segments, By Type

• 4.1 Introduction
  • 1.4.1 Tests and Kits
  • 1.4.2 Culture Media
  • 1.4.3 Automated Test Systems
  • 1.4.4 Consumables
• 4.2 By Type, Global Antimicrobial Susceptibility Test Market Size, 2019-2021

5 Impact of Covid-19 on Antimicrobial Susceptibility Test Segments, By Application

• 5.1 Overview
  • 5.5.1 Diagnostic Laboratories and Hospitals
  • 5.5.2 Pharmaceutical and Biotechnology Companies
  • 5.5.3 Research and Academic Institutes
  • 5.5.4 Contract Research Organizations
• 5.2 By Application, Global Antimicrobial Susceptibility Test Market Size, 2019-2021
  • 5.2.1 By Application, Global Antimicrobial Susceptibility Test Market Size by Application, 2019-2021

6 Geographic Analysis

• 6.1 Introduction
• 6.2 North America
  • 6.2.1 Macroeconomic Indicators of US
  • 6.2.2 US
  • 6.2.3 Canada
• 6.3 Europe
  • 6.3.1 Macroeconomic Indicators of Europe
  • 6.3.2 Germany
  • 6.3.3 France
  • 6.3.4 UK
  • 6.3.5 Italy
• 6.4 Asia-Pacific
  • 6.4.1 Macroeconomic Indicators of Asia-Pacific
  • 6.4.2 China
  • 6.4.3 Japan
  • 6.4.4 South Korea
  • 6.4.5 India
  • 6.4.6 ASEAN
• 6.5 Rest of World
  • 6.5.1 Latin America
  • 6.5.2 Middle East and Africa

7 Company Profiles

• 7.1 Bio-Rad Laboratories
  • 7.1.1 Bio-Rad Laboratories Business Overview
  • 7.1.2 Bio-Rad Laboratories Antimicrobial Susceptibility Test Quarterly Revenue, 2020
  • 7.1.3 Bio-Rad Laboratories Antimicrobial Susceptibility Test Product Introduction
  • 7.1.4 Bio-Rad Laboratories Response to COVID-19 and Related Developments
• 7.2 Beckman Coulter
  • 7.2.1 Beckman Coulter Business Overview
  • 7.2.2 Beckman Coulter Antimicrobial Susceptibility Test Quarterly Revenue, 2020
  • 7.2.3 Beckman Coulter Antimicrobial Susceptibility Test Product Introduction
  • 7.2.4 Beckman Coulter Response to COVID-19 and Related Developments
• 7.3 Thermo Fisher Scientific
  • 7.3.1 Thermo Fisher Scientific Business Overview
  • 7.3.2 Thermo Fisher Scientific Antimicrobial Susceptibility Test Quarterly Revenue, 2020
  • 7.3.3 Thermo Fisher Scientific Antimicrobial Susceptibility Test Product Introduction
  • 7.3.4 Thermo Fisher Scientific Response to COVID-19 and Related Developments
• 7.4 Becton, Dickinson and Company
  • 7.4.1 Becton, Dickinson and Company Business Overview
  • 7.4.2 Becton, Dickinson and Company Antimicrobial Susceptibility Test Quarterly Revenue, 2020
  • 7.4.3 Becton, Dickinson and Company Antimicrobial Susceptibility Test Product Introduction
  • 7.4.4 Becton, Dickinson and Company Response to COVID-19 and Related Developments
• 7.5 Conda
  • 7.5.1 Conda Business Overview
  • 7.5.2 Conda Antimicrobial Susceptibility Test Quarterly Revenue, 2020
  • 7.5.3 Conda Antimicrobial Susceptibility Test Product Introduction
  • 7.5.4 Conda Response to COVID-19 and Related Developments
• 7.6 Creative Diagnostics
  • 7.6.1 Creative Diagnostics Business Overview
  • 7.6.2 Creative Diagnostics Antimicrobial Susceptibility Test Quarterly Revenue, 2020
  • 7.6.3 Creative Diagnostics Antimicrobial Susceptibility Test Product Introduction
  • 7.6.4 Creative Diagnostics Response to COVID-19 and Related Developments
• 7.7 HiMedia Laboratories
  • 7.7.1 HiMedia Laboratories Business Overview
  • 7.7.2 HiMedia Laboratories Antimicrobial Susceptibility Test Quarterly Revenue, 2020
  • 7.7.3 HiMedia Laboratories Antimicrobial Susceptibility Test Product Introduction
  • 7.7.4 HiMedia Laboratories Response to COVID-19 and Related Developments
• 7.8 Alifax Holding S.p.A.
  • 7.8.1 Alifax Holding S.p.A. Business Overview
  • 7.8.2 Alifax Holding S.p.A. Antimicrobial Susceptibility Test Quarterly Revenue, 2020
  • 7.8.3 Alifax Holding S.p.A. Antimicrobial Susceptibility Test Product Introduction
  • 7.8.4 Alifax Holding S.p.A. Response to COVID-19 and Related Developments
• 7.9 Danaher Corporation (Cepheid)
  • 7.9.1 Danaher Corporation (Cepheid) Business Overview
  • 7.9.2 Danaher Corporation (Cepheid) Antimicrobial Susceptibility Test Quarterly Revenue, 2020
  • 7.9.3 Danaher Corporation (Cepheid) Antimicrobial Susceptibility Test Product Introduction
  • 7.9.4 Danaher Corporation (Cepheid) Response to COVID-19 and Related Developments
• 7.10 Biotron Healthcare
  • 7.10.1 Biotron Healthcare Business Overview
  • 7.10.2 Biotron Healthcare Antimicrobial Susceptibility Test Quarterly Revenue, 2020
  • 7.10.3 Biotron Healthcare Antimicrobial Susceptibility Test Product Introduction
  • 7.10.4 Biotron Healthcare Response to COVID-19 and Related Developments

8 Key Findings

9 Appendix

• 9.1 About US